Table 4.
Summary of patents related to the use of pharmaceutical technology approaches to improve the biopharmaceutical properties of DQ.
| Information | PATENTS | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| US5200418 | US20170360708A1 | WO2012/174121A2 | CN110898096 (A) | CN110585134 (A) | CN109620805 (A) | WO2019217957 | US20210059946 | US20210077480 | |
| Publication date | 4/6/93 | 12/21/17 | 12/20/12 | 3/24/20 | 12/20/19 | 4/16/19 | 11/14/19 | 03/04/21 | 03/18/21 |
| Inventors | Redman et al. [84] | Wang et al. [85] |
Pogany et al. [86] |
Chen et al. [87] |
Zeng et al. [88] |
Yuan et al. [89] |
Huang et al. [90] |
Wang et al. [91] |
Wang et al. [92] |
| Title | Cryptosporidiosis amelioration | Solid dispersion of decoquinate, a preparation process, and its application | Decoquinate prodrugs | Decoquinate microcapsules and preparation method thereof | Decoquinate liposome and preparation method and application thereof | Preparing method of decoquinate dry suspension | Quinoline compounds and their preparation and use as antimalarial agents | Intramuscular depot of decoquinate compositions and method of prophylaxis and treatment thereof | Nanoparticle formulations of decoquinate in the form of solid solution |
| Benefited | The Ohio State University Columbus, OSU (EUA). | Guangzhou Cas Lamvac Biotech Co., Ltd. (China). | University of Kansas (EUA). | Foshan Standart Bio Tech Co., Ltd. (China). | Guangzhou Lamvac Pharmaceutical tech Co., Ltd. (China). | Guangzhou Wens Dahuanong Biotechnology Co., Ltd. (EUA). | The Henry M. Jackson Foundation For The Advancement Of Military Medicine Inc. (EUA). | Bluelight Pharmatech Co., Ltd. (China). | Bluelight Pharmatech Co., Ltd. (China). |